Evidence map›Paper›PMID 41235418›Full record

ArticleChemical research in toxicology2025

Comparative Study of Molecular Descriptors and AI-Based Embeddings for Toxicity Prediction.

Magnus Gray, Leihong Wu

Abstract readComparative Study
In one paragraph

Article in Chemical research in toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Magnus GrayDivision of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. FDA, 3900 NCTR Rd, Jefferson, Arkansas 72079, United States.
Leihong WuDivision of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. FDA, 3900 NCTR Rd, Jefferson, Arkansas 72079, United States.ORCID 0000-0002-4093-3708

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate toxicity prediction is a critical component of pharmaceutical development and regulatory safety evaluation, traditionally relying on molecular descriptor-based models. This study compares the performance of descriptor-based features (Mordred, RDKit) with embeddings from ten AI language models applied to SMILES strings, chemical names, and simple descriptions, using logistic regression classifiers across the Tox21, ClinTox, and DILIst datasets. For the Tox21 dataset, Mordred achieved the highest average ROC-AUC of 0.855, outperforming language models. However, on specific endpoints, language models showed competitive performance, with MolBERT reaching an average ROC-AUC of 0.801 for SMILES-based embeddings. In contrast, language models outperformed descriptor models on the ClinTox dataset. While RDKit achieved an ROC-AUC of 0.721, GPT-3 reached 0.996 by using simple descriptions. Similarly, for the DILIst dataset, language models surpassed descriptor models, with GPT-3 achieving an ROC-AUC of 0.806 using chemical names, compared to RDKit's 0.620. These results demonstrate the promise of AI language models in predictive toxicology, particularly for specific toxicity endpoints and datasets. While molecular descriptors remain robust for multiendpoint predictions like Tox21, language models show superior performance on focused toxicity classifications such as ClinTox and DILIst. This study supports the future integration of molecular descriptors with textual embeddings to enhance overall performance and adaptability across diverse toxicity prediction tasks.

Indexed as

Artificial IntelligenceToxicity Tests

Identifiers

PMID41235418
PMCPMC12709611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.